Some Proteomics Firms Exploring Next-Generation Sequencing for Biomarker Research
May 06, 2011
Some Proteomics Firms Exploring Next-Generation Sequencing for Biomarker Research
Anticipating that NGS will become a key clinical tool in coming years, several proteomics firms and researchers are investigating it as a platform for protein biomarker detection assays that use nucleotides as capture agents, hoping to take advantage of the technology's precision and multiplexing ability.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Uppsala Team's ProteinSeq Assay Combines PLA and Next-Gen Sequencing for Protein Detection
October 7, 2011 / ProteoMonitor - Life Tech Developing Ion Torrent as a Platform for Proteomics Research
July 13, 2012 / ProteoMonitor - Expanded Proximity Ligation Assay Could Prove Valuable for Biomarker Studies, Top-Down Proteomics
May 13, 2011 / ProteoMonitor - Oligo-Based Protein Capture Tools Allow Simultaneous Reporting of Genetic, Proteomic Biomarker Data
October 21, 2011 / ProteoMonitor - LifeCodexx En Route to Launching Sequencing-Based Trisomy 21 Test by Year End
April 19, 2011 / Clinical Sequencing News